Cell. 2026 Mar 17. pii: S0092-8674(26)00224-2. [Epub ahead of print]
Tadashi Yamamuro,
Daisuke Katoh,
Guilherme Martins Silva,
Hiroshi Nishida,
Satoshi Oikawa,
Yusuke Higuchi,
Dandan Wang,
Masanori Fujimoto,
Naofumi Yoshida,
Mark Li,
Jihoon Shin,
Zezhou Zhao,
Jin-Seon Yook,
Lijun Sun,
Shingo Kajimura.
Mitochondria provide a variety of metabolites, in addition to ATP, to meet cell-specific needs. One such metabolite is phosphoenolpyruvate (PEP), which contains a higher-energy phosphate bond than ATP and has diverse biological functions. However, how mitochondria-generated PEP is delivered to the cytosol and fulfills cell-specific requirements remains elusive. Here, we show that SLC25A35 regulates mitochondrial PEP efflux and glyceroneogenesis in lipogenic cells that utilize the pyruvate-to-PEP bypass. Reconstitution and structural studies demonstrated PEP transport by SLC25A35 in a pH gradient-dependent manner. Loss of SLC25A35 in adipocytes impaired the conversion of mitochondrial PEP into glycerol-3-phosphate, thereby reducing glycerolipid synthesis. Significantly, hepatic inhibition of SLC25A35 in obese mice alleviated steatosis and improved systemic glucose homeostasis. Together, these results suggest that mitochondria facilitate glycerolipid synthesis by providing PEP via SLC25A35, offering lipogenic mitochondria as a target to limit glycerolipid synthesis, a pivotal step in the pathogenesis of hepatic steatosis and type 2 diabetes.
Keywords: bioenergetics; diabetes; glyceroneogenesis; hepatic steatosis; mitochondria; obesity